Pfizer Inc. has won regulatory approval for its hympavzi drug as a treatment for hemophilia A or B without inhibitors - making it the first antitissue-factor pathway inhibitor to be allowed for the ...
The highly transmissable Covid-19 sub-variant, XEC has arrived in New Zealand, with one epidemologist concerned people will die if there's an outbreak of the new strain. This strain is a mix of two ...